Baudax Bio (BXRX) Corporate Presentation from NobleCon18Research, News and Market Data on Baudax BioNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


5/5/2026
Technology
Release – SKYX Will Deploy its Technologies in its First European Hotel During a Master Renovation of The Grand Hotel du Parc, a Historical Hotel in La Bourboule, France – Part of Group OTT
SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced smart home and AI platform technology company with over 100 U.S. and...
6 min read
‌


5/5/2026
Natural Resources
Release – Century Lithium Provides Update on Permitting for the Angel Island Lithium Project, Nevada
Research News and Market Data on CYDVF May 5, 2026 – Vancouver, Canada – Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) (“Century Lithium” or the “Company”) is pleased to...
5 min read
‌


5/5/2026
Health
Release – Ocugen Provides Business Update with First Quarter 2026 Financial Results
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported first quarter 2026 financial results along with a general business...
11 min read
‌


5/5/2026
Health
Release – Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes
Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announced the pricing of $115 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034 (the “notes”) in a private offering (the “offering”)...
6 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.